S&P 500   2,995.99 (-0.36%)
DOW   26,788.10 (-0.15%)
QQQ   191.85 (-0.80%)
AAPL   239.96 (-0.23%)
FB   182.34 (-3.91%)
MSFT   136.37 (-1.49%)
GOOGL   1,241.20 (-0.25%)
AMZN   1,765.73 (-1.12%)
CGC   21.15 (+3.93%)
NVDA   195.61 (-0.20%)
MU   44.66 (-1.24%)
BABA   169.89 (-2.09%)
GE   9.06 (+3.07%)
TSLA   255.58 (+0.82%)
AMD   31.51 (-1.62%)
T   38.17 (-0.16%)
F   9.07 (+0.44%)
ACB   3.58 (-2.98%)
PRI   125.80 (+0.09%)
NFLX   266.69 (-4.09%)
BAC   31.20 (+0.58%)
GILD   65.86 (+1.00%)
DIS   132.40 (+1.64%)
S&P 500   2,995.99 (-0.36%)
DOW   26,788.10 (-0.15%)
QQQ   191.85 (-0.80%)
AAPL   239.96 (-0.23%)
FB   182.34 (-3.91%)
MSFT   136.37 (-1.49%)
GOOGL   1,241.20 (-0.25%)
AMZN   1,765.73 (-1.12%)
CGC   21.15 (+3.93%)
NVDA   195.61 (-0.20%)
MU   44.66 (-1.24%)
BABA   169.89 (-2.09%)
GE   9.06 (+3.07%)
TSLA   255.58 (+0.82%)
AMD   31.51 (-1.62%)
T   38.17 (-0.16%)
F   9.07 (+0.44%)
ACB   3.58 (-2.98%)
PRI   125.80 (+0.09%)
NFLX   266.69 (-4.09%)
BAC   31.20 (+0.58%)
GILD   65.86 (+1.00%)
DIS   132.40 (+1.64%)
Log in

Iradimed Stock Price, News & Analysis (NASDAQ:IRMD)

$23.63
+0.19 (+0.81 %)
(As of 10/22/2019 04:00 PM ET)
Today's Range
$22.86
Now: $23.63
$24.08
50-Day Range
$18.48
MA: $21.63
$23.74
52-Week Range
$16.68
Now: $23.63
$30.90
Volume76,368 shs
Average Volume68,271 shs
Market Capitalization$268.67 million
P/E Ratio54.95
Dividend YieldN/A
Beta1.56
IRADIMED CORPORATION develops, manufactures, markets, and distributes magnetic resonance imaging (MRI) compatible medical devices, and related accessories and services in the United States and internationally. It offers MRI compatible intravenous (IV) infusion pump system with associated disposable IV tubing sets; and MRI compatible patient vital signs monitoring system. Read More…

Industry, Sector and Symbol

Industry Surgical & medical instruments
Sub-IndustryN/A
SectorMedical
Current SymbolNASDAQ:IRMD
CUSIPN/A
Phone407-677-8022

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$30.44 million
Cash Flow$0.60 per share
Book Value$3.84 per share

Profitability

Net Income$6.30 million

Miscellaneous

Employees95
Market Cap$268.67 million
Next Earnings Date10/30/2019 (Confirmed)
OptionableNot Optionable

Receive IRMD News and Ratings via Email

Sign-up to receive the latest news and ratings for IRMD and its competitors with MarketBeat's FREE daily newsletter.


Iradimed (NASDAQ:IRMD) Frequently Asked Questions

What is Iradimed's stock symbol?

Iradimed trades on the NASDAQ under the ticker symbol "IRMD."

How were Iradimed's earnings last quarter?

Iradimed Corp (NASDAQ:IRMD) announced its quarterly earnings data on Tuesday, July, 30th. The medical equipment provider reported $0.17 earnings per share for the quarter, beating analysts' consensus estimates of $0.12 by $0.05. The medical equipment provider earned $9.23 million during the quarter, compared to analysts' expectations of $8.91 million. Iradimed had a net margin of 23.92% and a return on equity of 14.78%. View Iradimed's Earnings History.

When is Iradimed's next earnings date?

Iradimed is scheduled to release their next quarterly earnings announcement on Wednesday, October 30th 2019. View Earnings Estimates for Iradimed.

How can I listen to Iradimed's earnings call?

Iradimed will be holding an earnings conference call on Wednesday, October 30th at 12:00 AM Eastern. Interested parties can register for or listen to the call using this link or dial in at Not Available.

What guidance has Iradimed issued on next quarter's earnings?

Iradimed issued an update on its third quarter 2019 earnings guidance on Tuesday, July, 30th. The company provided earnings per share (EPS) guidance of $0.14-0.16 for the period, compared to the Thomson Reuters consensus earnings per share estimate of $0.16. The company issued revenue guidance of $9.7-10 million, compared to the consensus revenue estimate of $9.84 million.

Has Iradimed been receiving favorable news coverage?

Media coverage about IRMD stock has trended very negative recently, InfoTrie Sentiment reports. The research firm ranks the sentiment of news coverage by monitoring more than six thousand blog and news sources. The firm ranks coverage of companies on a scale of -5 to 5, with scores closest to five being the most favorable. Iradimed earned a news sentiment score of -3.6 on InfoTrie's scale. They also gave news stories about the medical equipment provider a news buzz of 10.0 out of 10, meaning that recent news coverage is extremely likely to have an effect on the stock's share price in the next few days. View News Stories for Iradimed.

Are investors shorting Iradimed?

Iradimed saw a decline in short interest in September. As of September 15th, there was short interest totalling 427,200 shares, a decline of 5.2% from the August 15th total of 450,600 shares. Based on an average daily trading volume, of 79,700 shares, the days-to-cover ratio is presently 5.4 days. Approximately 7.9% of the shares of the stock are short sold. View Iradimed's Current Options Chain.

Who are some of Iradimed's key competitors?

What other stocks do shareholders of Iradimed own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Iradimed investors own include NVIDIA (NVDA), Intuitive Surgical (ISRG), Micron Technology (MU), Palo Alto Networks (PANW), BioTelemetry (BEAT), Cisco Systems (CSCO), Alphabet (GOOG), IntriCon (IIN), Paypal (PYPL) and GrubHub (GRUB).

Who are Iradimed's key executives?

Iradimed's management team includes the folowing people:
  • Mr. Roger E. Susi, Founder, Chairman, CEO & Pres (Age 66)
  • Mr. Christopher K. Scott, CFO & Sec. (Age 49)
  • Mr. John McCreery, Chief Operating Officer (Age 64)
  • Mr. Brent Johnson, Exec. VP of Worldwide Sales & Marketing (Age 60)
  • Mr. Louis Waldman, Controller (Age 64)

Who are Iradimed's major shareholders?

Iradimed's stock is owned by a variety of of institutional and retail investors. Top institutional shareholders include Roubaix Capital LLC (0.58%) and Navellier & Associates Inc (0.25%). Company insiders that own Iradimed stock include Brent Johnson, Christopher K Scott, Francis X Casey, John K Mccreery, Louis S Waldman, Monty K Allen, Roger E Susi and Steven M Nardi. View Institutional Ownership Trends for Iradimed.

Which major investors are selling Iradimed stock?

IRMD stock was sold by a variety of institutional investors in the last quarter, including Navellier & Associates Inc. Company insiders that have sold Iradimed company stock in the last year include Brent Johnson, Louis S Waldman, Monty K Allen and Steven M Nardi. View Insider Buying and Selling for Iradimed.

Which major investors are buying Iradimed stock?

IRMD stock was acquired by a variety of institutional investors in the last quarter, including Roubaix Capital LLC. View Insider Buying and Selling for Iradimed.

How do I buy shares of Iradimed?

Shares of IRMD can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.

What is Iradimed's stock price today?

One share of IRMD stock can currently be purchased for approximately $23.63.

How big of a company is Iradimed?

Iradimed has a market capitalization of $268.67 million and generates $30.44 million in revenue each year. The medical equipment provider earns $6.30 million in net income (profit) each year or $0.43 on an earnings per share basis. Iradimed employs 95 workers across the globe.View Additional Information About Iradimed.

What is Iradimed's official website?

The official website for Iradimed is http://www.iradimed.com/.

How can I contact Iradimed?

Iradimed's mailing address is 1025 Willa Springs Dr., Winter Springs FL, 32708. The medical equipment provider can be reached via phone at 407-677-8022 or via email at [email protected]


MarketBeat Community Rating for Iradimed (NASDAQ IRMD)

Community Ranking:  2.5 out of 5 (star star half star)
Outperform Votes:  210 (Vote Outperform)
Underperform Votes:  213 (Vote Underperform)
Total Votes:  423
MarketBeat's community ratings are surveys of what our community members think about Iradimed and other stocks. Vote "Outperform" if you believe IRMD will outperform the S&P 500 over the long term. Vote "Underperform" if you believe IRMD will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 10/22/2019 by MarketBeat.com Staff

Featured Article: Bull Market

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel